ThermoFisher-Qiagen deal off
- Thermo Fisher has a revenue of $24B
- Qiagen is a molecular diagnostics company
- originally $11,5B deal
- couldn't find the shareholder support - only 47 % out of 66 % needed shares were tendered
Source: Medtechdive
Read more: https://www.linkedin.com/feed/update/urn:li:activity:6699664011723587584

#medicaldevices #mergersandacquisitions #moleculardiagnostics